Shinji Tsumi

Shinji Tsumi has extensive experience in the field of oncology, having served in various leadership roles at Daiichi Sankyo US from July 2012 to April 2023, including Vice President and Head of Translational Science Oncology, Executive Director and Head of Oncology Translational Strategy and Execution (Early Stage), and Senior Director/Group Leader. Prior to this, Shinji Tsumi held positions as a Research Fellow and Visiting Fellow at the NCI/NIH between January 2005 and January 2012. Shinji Tsumi obtained a Doctorate in Pharmaceutical Sciences from Okayama University, where the academic journey took place from January 1994 to January 2003.